SLC44A1 Antibody | CSB-PA871404

(No reviews yet) Write a Review
SKU:
CSB-PA871404
Availability:
3 to 7 Working Days
  • SLC44A1 Antibody
  • The image on the left is immunohistochemistry of paraffin-embedded Human prostate cancer tissue using CSB-PA871404 (SLC44A1 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)
€315.80 - €488.70

Description

SLC44A1 Antibody | CSB-PA871404 | Cusabio

SLC44A1 Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: SLC44A1

Aliases: solute carrier family 44 (choline transporter), member 1

Background: CD92, also known as SLC44A1 (solute carrier family 44, member 1), CDw92 or CTL1 (choline transporter-like protein 1), is a 657 amino acid multi-pass membrane protein that belongs to the choline transporter-like family of solute carrier proteins. Expressed in cells that are associated with the hematopoietic system, CD92 functions as a choline transporter that may be involved in myelin production, as well as in membrane synthesis. Human CD92 shares 96% sequence homology with its mouse counterpart, suggesting a conserved role between species. Three isoforms of CD92 exist due to alternative splicing events.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: Q8WWI5

Host Species: Rabbit

Species Reactivity: Human, Mouse, Rat

Immunogen: Synthetic peptide of human SLC44A1

Immunogen Species: Human

Applications: ELISA, IHC

Tested Applications: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

Purification Method: Antigen affinity purification

Dilution Ratio1: ELISA:1:1000-1:2000

Dilution Ratio2: IHC:1:25-1:100

Dilution Ratio3:

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Signal Transduction

Research Areas: Cancer;Metabolism;Signal transduction

View AllClose

0 Reviews

View AllClose